Detalhe da pesquisa
1.
Long-Term Outcomes of Patients With HCV-Associated Cryoglobulinemic Vasculitis After Virologic Cure.
Gastroenterology
; 155(2): 311-315.e6, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29705529
2.
Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Ann Hematol
; 96(3): 405-410, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28035434
3.
Response-guided peg-interferon plus ribavirin treatment duration in chronic hepatitis C: meta-analyses of randomized, controlled trials and implications for the future.
Hepatology
; 54(3): 789-800, 2011 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-21674553
4.
Peginterferon plus ribavirin and sustained virological response in HCV-related cirrhosis: outcomes and factors predicting response.
Am J Gastroenterol
; 105(10): 2164-72; quiz 2173, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20700116
5.
Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients.
Hepatology
; 49(1): 22-31, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19085908
6.
Life-threatening cryoglobulinemia: clinical and immunological characterization of 29 cases.
Semin Arthritis Rheum
; 36(3): 189-96, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16996578
7.
Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C.
World J Gastroenterol
; 21(17): 5421-6, 2015 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25954117
8.
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV co-infected patients.
AIDS
; 18(13): F27-36, 2004 Sep 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-15316335
9.
Expected developments in hepatology.
Best Pract Res Clin Gastroenterol
; 16(6): 957-70, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12473301
10.
[Use of complementary and alternative medicine in patients with chronic hepatitis C]. / Utilización de las medicinas alternativas y complementarias por los pacientes con hepatitis C crónica.
Med Clin (Barc)
; 122(9): 334-5, 2004 Mar 13.
Artigo
em Espanhol
| MEDLINE | ID: mdl-15033052
11.
[Pharmacological agents for the treatment of chronic hepatitis B]. / Fármacos para el tratamiento de la hepatitis B crónica.
Gastroenterol Hepatol
; 31(3): 120-8, 2008 Mar.
Artigo
em Espanhol
| MEDLINE | ID: mdl-18341843
12.
Development and validation of two models for early prediction of response to therapy in genotype 1 chronic hepatitis C.
Hepatology
; 43(1): 72-80, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16374857
13.
Peginterferon-alfa2a plus ribavirin for 48 versus 72 weeks in patients with detectable hepatitis C virus RNA at week 4 of treatment.
Gastroenterology
; 131(2): 451-60, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16890599
14.
Dynamics of hepatitis C virus NS5A quasispecies during interferon and ribavirin therapy in responder and non-responder patients with genotype 1b chronic hepatitis C.
J Gen Virol
; 86(Pt 4): 1067-1075, 2005 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15784900
15.
Influence of hepatitis B virus genotype on the long-term outcome of chronic hepatitis B in western patients.
Gastroenterology
; 123(6): 1848-56, 2002 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-12454842
16.
Hepatitis C: who should you treat and how?
Blood Purif
; 20(1): 124-36, 2002.
Artigo
em Inglês
| MEDLINE | ID: mdl-11803170